Get the Stockscreener App
3.46
0.58%
0.02
After Hours:
6.76
3.30
+95.38%
Cryo Cell International Inc stock is traded at $3.46, with a volume of 1,635.
It is up +0.58% in the last 24 hours and down -3.35% over the past month.
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
See More
Previous Close:
$3.44
Open:
$3.46
24h Volume:
1,635
Relative Volume:
0.15
Market Cap:
$27.87M
Revenue:
$31.28M
Net Income/Loss:
$-2.67M
P/E Ratio:
-10.44
EPS:
-0.3315
Net Cash Flow:
$4.94M
1W Performance:
-4.42%
1M Performance:
-3.35%
6M Performance:
-15.45%
1Y Performance:
-27.92%
1-Day Range:
$3.46
$3.46
1-Week Range:
$3.42
$3.69
52-Week Range:
$2.72
$6.35
Cryo Cell International Inc Stock (CCEL) Company Profile
Name
Cryo Cell International Inc
Sector
Industry
Phone
813 749 2100
Address
700 Brooker Creek Boulevard, Suite 1800, Oldsmar
Compare CCEL vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 5.10 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.21 | 2.92B | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
7.49 | 430.62M | 52.15M | -21.46M | 0 | -0.4675 |
GOODO
Gladstone Commercial Corporation
|
20.20 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
3.12 | 290.00M | 2.07B | -1.42B | -1.37B | -0.6765 |
DWLD
Davis Select Worldwide ETF
|
46.89 | 0 | 0 | 0 | 0 | 0.00 |
Cryo Cell International Inc Stock (CCEL) Latest News
Cryo-Cell International (CCEL) Short Interest & Short Float | Updated May 2026 - MarketBeat
TradingKey - TradingKey
Cryo-Cell International FY Net Income USD -2. - Moomoo
Cryo-Cell Plan Accepted to Regain NYSE Compliance - The Globe and Mail
How Cryo-Cell (CCEL) is positioning for the next five years (Weakens) 2026-05-08Community Pattern Alerts - newser.com
Cryo-Cell International’s Compliance Plan Accepted by NYSE American - geneonline.com
NYSE accepts Cryo-Cell plan to regain listing compliance By Investing.com - Investing.com Australia
NYSE accepts Cryo-Cell plan to regain listing compliance - Investing.com
Cryo-Cell Gets NYSE American Approval for Compliance Plan - Moomoo
Cryo-Cell Receives Acceptance of Compliance Plan From NYSE American - The Joplin Globe
NYSE American accepts Cryo-Cell (NYSE: CCEL) plan to regain compliance - Stock Titan
How Cryo-Cell (CCEL) performance compares to expectations (+1.42%) 2026-05-08Bearish Pattern - newser.com
Cryo-Cell receives renewed FACT accreditation through 2029 By Investing.com - Investing.com Nigeria
Cryo-Cell receives renewed FACT accreditation through 2029 - Investing.com
Cryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood Banks - Business Wire
Emerging Sub-Segments Transforming the Stem Cell and Cord Blood Banking Market Landscape - openPR.com
CCEL (Cryo-Cell International Inc.) posts positive Q1 2026 EPS against expected loss, shares rise modestly.Seasonality - Xã Thanh Hà
Cryo-Cell (CCEL) Market Dynamics | Q1 2026: Better Than ExpectedIPO - Cổng thông tin điện tử tỉnh Lào Cai
Wall Street Analysts Are Neutral on Top Healthcare Picks - The Globe and Mail
Cryo-Cell International Faces NYSE American Compliance Review and Potential Delisting Risk Ahead of 2027 Deadline - The Globe and Mail
CCEL Reports Drop in Q1 Revenue Compared to Last Year - GuruFocus
CRYO Cell International Q3 10-Q: Revenue $7.68M, Cost of Sales $1.66M - TradingView
[10-Q] CRYO CELL INTERNATIONAL INC Quarterly Earnings Report - Stock Titan
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2026 Financial Results - Bluefield Daily Telegraph
Cryo-Cell International, Inc. Reports Earnings Results for the First Quarter Ended February 28, 2026 - marketscreener.com
CEO Change: Will Cryo Cell International Inc benefit from rising consumer demandMarket Risk Report & Verified Momentum Stock Watchlist - baoquankhu1.vn
Growth Value: Should I trade or invest in Cryo Cell International Inc2026 Fundamental Recap & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Market Fear: Will Cryo Cell International Inc benefit from AI trends2026 Price Swings & Technical Entry and Exit Tips - baoquankhu1.vn
Dow Update: What dividend growth rate does Cryo Cell International Inc offerWeekly Trend Report & Fast Entry and Exit Trade Plans - baoquankhu1.vn
How does earnings affect Cryo-Cell (CCEL) Stock | Price at $3.67, Down 0.68%ATR Levels - Newser
Is Cryo-Cell (CCEL) Stock Rebounding | CCEL Q4 Earnings: Misses Estimates by $0.38Debt/EBITDA - Newser
CCEL PE Ratio & Valuation, Is CCEL Overvalued - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
Gap Down: What is the cash position of Cryo Cell International Inc2026 Pullback Review & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Camac Fund takes 5.3% activist stake in Cryo-Cell (CCEL) with 430,900 shares - stocktitan.net
Eric Shahinian Takes Activist Stake at Cryo-Cell International with 5.3% Stake - tradingview.com
CEO Change: Will Cryo Cell International Inc benefit from sector rotationWeekly Investment Summary & Growth Focused Entry Point Reports - baoquankhu1.vn
Stem Cell Banking Market Set to Boom by 2033Key Opportunities - openPR.com
Stem Cell Banking Market Size, Growth & Analysis, 2034 - Market Data Forecast
Cryo-Cell International, Inc.Common Stock (NY: CCEL - The Chronicle-Journal
CCEL (Cryo-Cell) NASDAQ pre-market -100.00% 16 Mar 2026: check listing risk - Meyka
Cryo-Cell International receives NYSE American notice over listing non-compliance - MSN
Panic Selling: What is the cash position of Cryo Cell International Inc2026 Summary & Detailed Earnings Play Alerts - baoquankhu1.vn
Cryo-Cell receives NYSE American non-compliance notice By Investing.com - Investing.com Australia
Cryo-Cell Faces NYSE American Listing Compliance Challenges - The Globe and Mail
Cryo-Cell receives NYSE American non-compliance notice - Investing.com Nigeria
Cryo-Cell International Receives NYSE American Continued Listing Notice After Failing Compliance Standards - Minichart
Cryo Cell International Inc Stock (CCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.74%
0.15%
Cap:
|
Volume (24h):